Skip to main content
TipRanks
Go Ultimate75% OFF

ChronoScale (23E1) Stock Price & Analysis

1 Followers

23E1 Stock Chart & Stats

€8.61-€0.39(-4.33%)
At close: 5:30 PM GMT+1
€15€17.5€20Jul 16Jul 30Aug 13Sep 28Oct 14
Day’s Range
EUR 8.61 - EUR 8.61
52-Week Range
EUR 3.28 - EUR 25.20
Previous Close
EUR 9.00
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 1.24B
Enterprise Value
EUR 2.74B
Total Cash (Recent Filing)
EUR 15.22M
Total Debt (Recent Filing)
EUR 111.06M
Price to Earnings (P/E)
―
Beta
1.92
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Exceptional Revenue Growth

Revenue expansion of roughly 341% demonstrates strong recent demand and materially increases the potential scale of the business. Maintaining gross margin near 53% during this growth suggests the offering has reasonable unit economics, although continued execution is needed to convert scale into profits.

Positive Operating Cash Flow

The move to positive operating and free cash flow improves internal funding capacity and reduces immediate reliance on external capital. If sustained, cash generation could support deployments and operating needs while gradually improving financial flexibility despite the company’s continuing accounting losses.

Focused AI Infrastructure Pipeline

Selling Ekso Bionics and expanding AI infrastructure contracts concentrates management attention and capital on the accelerated-compute platform. The larger contracted pipeline and Microsoft deployment provide a clearer strategic focus and could support recurring infrastructure growth as projects are delivered.

Bears Say

Deepening Operating Losses

The company has not yet demonstrated operating leverage: rapid revenue growth is being outweighed by a cost structure that produces materially larger losses. Persistent negative profitability can consume capital, limit reinvestment capacity, and weaken the durability of the growth model.

Rising Leverage

The sharp increase in leverage raises financial risk while returns remain negative, leaving the enlarged debt burden unsupported by current earnings. Higher obligations can constrain capital allocation and make the company more dependent on successful growth, refinancing, or continued cash-flow improvement.

Deployment And Funding Execution Risk

A stronger contracted pipeline does not eliminate the challenge of building and deploying large-scale AI infrastructure. Delays or insufficient funding could defer revenue realization, increase capital requirements, and prevent the strategic focus from translating into durable operating results.

ChronoScale News

23E1 FAQ

What was ChronoScale’s price range in the past 12 months?
ChronoScale lowest stock price was €3.28 and its highest was €25.20 in the past 12 months.
What is ChronoScale’s market cap?
ChronoScale’s market cap is €1.24B.
When is ChronoScale’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ChronoScale’s earnings last quarter?
ChronoScale released its earnings results on Oct 15, 2026. The company reported -€0.161 earnings per share for the quarter, missing the consensus estimate of -€0.098 by -€0.062.
Is ChronoScale overvalued?
According to Wall Street analysts ChronoScale’s price is currently Undervalued.
Does ChronoScale pay dividends?
ChronoScale does not currently pay dividends.
What is ChronoScale’s EPS estimate?
ChronoScale’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ChronoScale have?
ChronoScale has 145,637,450 shares outstanding.
What happened to ChronoScale’s price movement after its last earnings report?
ChronoScale reported an EPS of -€0.161 in its last earnings report, missing expectations of -€0.098. Following the earnings report the stock price went down -10.779%.
Which hedge fund is a major shareholder of ChronoScale?
Currently, no hedge funds are holding shares in DE:23E1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology